HR 919 119th Congress
Chronic Disease Flexible Coverage Act
To codify Internal Revenue Service guidance relating to treatment of certain services and items for chronic conditions as meeting the preventive care deductible safe harbor for purposes of high deductible health plans in connection with health savings accounts.
Official Title as Introduced Congress.gov
Open official Congress.gov recordSource-linked procedural record
Bill journey
This is a chronology, not a progress score. Politically.com does not classify stages or infer what comes next. Records sharing a date are grouped because not every source field supplies a time.
-
Introduction Congress.gov
Introduced
Introduced in the House.
Open bill recordOfficial action Congress.gov
Referred to the House Committee on Ways and Means.
Open bill recordOfficial action Congress.gov
Introduced in House
Open bill recordOfficial action Congress.gov
Introduced in House
Open bill recordText version Congress.gov
Introduced in House
A dated text-version record is available.
Open text record -
Text version Congress.gov
Engrossed in House
A dated text-version record is available.
Open text recordOfficial action Congress.gov · 2:16 pm UTC
Mr. Smith (MO) moved to suspend the rules and pass the bill.
Open bill recordOfficial action Congress.gov · 2:16 pm UTC
Considered under suspension of the rules. (consideration: CR H964-966)
Open bill recordOfficial action Congress.gov · 2:16 pm UTC
DEBATE - The House proceeded with forty minutes of debate on H.R. 919.
Open bill recordOfficial action Congress.gov · 2:29 pm UTC
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H964)
Open bill recordOfficial action Congress.gov · 2:29 pm UTC
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H964)
Open bill recordOfficial action Congress.gov · 2:29 pm UTC
Motion to reconsider laid on the table Agreed to without objection.
Open bill record -
Official action Congress.gov
Received in the Senate and Read twice and referred to the Committee on Finance.
Open bill recordText version Congress.gov
Referred in Senate
A dated text-version record is available.
Open text record
View the complete bill journey as an accessible table
| Date and time | Record | Official detail | Source |
|---|---|---|---|
| IntroductionIntroduced | Introduced in the House. | Congress.gov | |
| Official actionReferred to the House Committee on Ways and Means. | No additional detail supplied.IntroReferral · House floor actions · Code H11100 | Congress.gov | |
| Official actionIntroduced in House | No additional detail supplied.IntroReferral · Library of Congress · Code Intro-H | Congress.gov | |
| Official actionIntroduced in House | No additional detail supplied.IntroReferral · Library of Congress · Code 1000 | Congress.gov | |
| Text versionIntroduced in House | A dated text-version record is available. | Congress.gov | |
| Text versionEngrossed in House | A dated text-version record is available. | Congress.gov | |
| Official actionMr. Smith (MO) moved to suspend the rules and pass the bill. | No additional detail supplied.Floor · House floor actions · Code H30300 | Congress.gov | |
| Official actionConsidered under suspension of the rules. (consideration: CR H964-966) | No additional detail supplied.Floor · House floor actions · Code H30000 | Congress.gov | |
| Official actionDEBATE - The House proceeded with forty minutes of debate on H.R. 919. | No additional detail supplied.Floor · House floor actions · Code H8D000 | Congress.gov | |
| Official actionOn motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H964) | No additional detail supplied.Floor · House floor actions · Code H37300 | Congress.gov | |
| Official actionPassed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H964) | No additional detail supplied.Floor · Library of Congress · Code 8000 | Congress.gov | |
| Official actionMotion to reconsider laid on the table Agreed to without objection. | No additional detail supplied.Floor · House floor actions · Code H38310 | Congress.gov | |
| Official actionReceived in the Senate and Read twice and referred to the Committee on Finance. | No additional detail supplied.IntroReferral · Senate | Congress.gov | |
| Text versionReferred in Senate | A dated text-version record is available. | Congress.gov |
House roll calls join only on matching Congress, legislation type, and number. Senate roll calls join only on matching source-supplied document type and number, not question text. Committee and related-measure relationships have no date in their relationship records and therefore are counted above but never placed on the chronology.
Congressional Research Service
CRS summary
Chronic Disease Flexible Coverage ActThis bill provides statutory authority for guidance from the Internal Revenue Service (IRS) that expands the types of preventive care that may be offered under a high deductible health plan (HDHP) without requiring a deductible or with a deductible below the minimum threshold.Under current law, to be considered health savings account-eligible, an HDHP must have a deductible above a certain minimum threshold amount, which is adjusted annually. However, an HDHP may cover certain types of preventive care without requiring a deductible or with a deductible below the minimum threshold. The IRS issued guidance expanding the types of preventive care that may be covered by an HDHP without requiring a deductible or with a deductible below the minimum threshold to includeangiotensin converting enzyme inhibitors for individuals with congestive heart failure, diabetes, or coronary artery disease;anti-resorptive therapy for individuals with osteoporosis or osteopenia;beta-blockers for individuals with congestive heart failure or coronary artery disease;blood pressure monitors for individuals with hypertension;inhaled corticosteroids and peak flow meters for individuals with asthma;insulin and other glucose lowering agents, retinopathy screening, glucometers, and hemoglobin A1c testing for individuals with diabetes;international normalized ratio testing for individuals with liver disease or bleeding disorders;low-density lipoprotein testing for individuals with heart disease;statins for individuals with heart disease or diabetes; andselective serotonin reuptake inhibitors for individuals with depression. The bill provides statutory authority for the IRS's guidance.
Official documents
Text versions
- Referred in SenateMar 5, 2025
- Engrossed in HouseMar 4, 2025
- Introduced in HouseFeb 4, 2025